Background: Diabetes mellitus is a metabolic disorder caused by a partial or complete shortage of insulin, which leads to elevated blood sugar levels and long-term vascular and neurological complications. One of the side effects of uncontrolled diabetes mellitus is sensory hearing loss. Sensorineural hearing loss has a signicant inuence on patients' quality of life because it is directly linked to physical, psychological, and cognitive dysfunction. Methods: ENT department at Sri Siddhartha Medical College in Tumkur did a prospective study over the course of 22 months that included 75 type 2 diabetic patients of both sexes between the ages of 30 and 65. All subjects have undergone FBS, PPBS, and HbA1c tests, followed by PTAto assess hearing loss. Age, gender, laterality, degree of hearing loss, length of DM, and HbA1c levels were compared with the occurrence of SNHL. Results: Of the 75 DM patients in our study, 64 (85.3%) had SNHL, while 11 individuals were normal. The majority of the patients, or 39 (52%), are between the ages of 51 and 65. The majority of patients (64%) are men aged 48. Males outnumbered females by a factor of 1.7:1. 4 patients (7%) have hearing loss in both ears, 34 (53%) only have hearing loss in the left ear, and 26 (40%) only have hearing loss in the right ear. The majority of patients, or 32 patients (51%) are in the group with mild hearing loss, followed by 19 patients (30%) with moderate hearing loss, 7 patients (10%) with moderately severe hearing loss, 4 patients (6%) with severe hearing loss, and 2 patients (3%) with profound hearing loss. patients who have diabetes.
Background: Middle ear diseases are the most common conditions in otology, proper evaluation of these patients are mandatory. Microscopic examination of ear is the routine procedure in evaluating the ndings with certain limitations. Introduction of endoscopy had led to the attempts of utilizing it in otolaryngology for the evaluation of middle ear spaces. This is Materials And Methods: a Hospital based comparative study, patients attending outpatient department of ENT, Sri Siddhartha Medical College, of both genders between 18 to 60 years of age, diagnosed to have disease of middle ear have been enrolled for the study after obtaining the written informed consent. Study parameters of both the groups were compared. Among 124 participants, our study showed that 29 participants (23.38 %) Eustachian Results: tube opening is visible through the microscope, while it is visible in 111 participants (89.51%) under otoendoscopy. In 33 participants (26.61%) epitympanum is visible under microscopy, compared to otoendoscope were 95participants (76.61%) are visible. Hypotympanum is visible in 58 participants (46.77%) with microscope and 112(90.3%) participants with otoendoscope. Visualization of sinus tympani in 9 participants (7.2%) is possible through microscope whereas it is visible in 91 participants (73.3%) through otoendoscope. Facial recess is visible in 8 participants (6.4%) through microscopy and in 89(71.7%) participants through otoendoscope. Oval window is visible in 12 participants (9.6%) through microscope whereas it is visible in 89 (71.7%) participants through Otoendoscopy. The p-value of all the above parameters is less than 0.001; indicating study is statistically signicant thus otoendoscope has a better visualisation of these structures. No statistically signicant difference between the examination of the external auditory canal and round window using a microscope and otoendoscope has been obtained. Oto- Conclusion: microscopy despite having the better three dimensional images, otoendoscope gives a better visualization of middle ear structure in evaluating diseases of middle ear. Therefore we conclude that Otoendoscopic examination should be mandatory along with routine Otomicroscopic examination.
Background: Chronic otitis media (COM) is most common disease seen by ENT surgeon. Tympanoplasty using temporalis fascia as graft is routine treatment procedure while Platelet Rich Plasma (PRP)is newer treatment procedure. Methods: Prospective Study conducted on participants admitted with Chronic otitis media in the Otorhinolaryngology department of Sri Siddhartha Medical College hospital and Research Centre, Tumkur from December 2020 to June 2022 which includes 60 participants and were divided into two groups PRP group (30 participants) where PRP used as graft material and T group (30 participants) where temporalis fascia was used as graft material and follow up done at 3rd month and 6th month for assessing closure of perforation and for hearing improvement using pure tone audiometry. Results: Among 30 cases of PRP group, there were 29 cases of closure of perforation (96.67 %) and 1 case had no closure of perforation (3.33 %). Among 30 cases of T group, there were 28 cases of closure of perforation (93.33%) and 2 cases had no closure of perforation (6.67%). The p-value calculated between the groups with pre operative mean air bone gap values was 0.2210 and that with post operative values was 0.1835; indicating no signicant difference between the groups during follow up at 6 months.Background: Chronic otitis media (COM) is most common disease seen by ENT surgeon. Tympanoplasty using temporalis fascia as graft is routine treatment procedure while Platelet Rich Plasma (PRP)is newer treatment procedure. Methods: Prospective Study conducted on participants admitted with Chronic otitis media in the Otorhinolaryngology department of Sri Siddhartha Medical College hospital and Research Centre, Tumkur from December 2020 to June 2022 which includes 60 participants and were divided into two groups PRP group (30 participants) where PRP used as graft material and T group (30 participants) where temporalis fascia was used as graft material and follow up done at 3rd month and 6th month for assessing closure of perforation and for hearing improvement using pure tone audiometry. Results: Among 30 cases of PRP group, there were 29 cases of closure of perforation (96.67 %) and 1 case had no closure of perforation (3.33 %). Among 30 cases of T group, there were 28 cases of closure of perforation (93.33%) and 2 cases had no closure of perforation (6.67%). The p-value calculated between the groups with pre operative mean air bone gap values was 0.2210 and that with post operative values was 0.1835; indicating no signicant difference between the groups during follow up at 6 months.
Background: Chronic otitis media is an inammatory process in middle ear cleft which is treated by a common otological procedure tympanoplasty to reconstruct the tympanic membrane and to restore sound-conducting mechanism. Rigid endoscope in transcanal interlay tympanoplasty has signicant advantage as it provides magnied, and wide angle view, with better success rate and postoperative hearing gain. The Aims and objectives were to assess the outcome of endoscopic interlay tympanoplasty, in terms of graft uptake, hearing improvement and rate of complications in cases of inactive mucosal chronic suppurative otitis media. Methods: This prospective study was conducted for 1 year at our institution in 50 patients having conductive hearing loss with dry, central perforation. All patients underwent transcanal endoscopic interlay tympanoplasty and were followed up for 3months to determine the graft uptake, hearing improvement and rate of complications. Results: Graft uptake rate in the present study was found to be 98% with residual perforation as a complication in 2% patients and no other complications were encountered. Post operatively air bone gap (ABG) after 12 weeks found to be < 20 dB ABG in 84% patients. Conclusion: Endoscopic interlay tympanoplasty is a effective method with high success rate both in terms of graft uptake as well as post operative hearing improvement and can be implemented in all cases of inactive mucosal COM.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.